SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Revenue reduced marginally to stand at Rs. 721.10 millions during the quarter ended June 2022. The figure stood at Rs. 727.52 millions during the year-ago period.Profit after Tax for the quarter ended June 2022 saw a decline of -58.07% from Rs. 185.48 millions to Rs. 77.78  millions.A decline of 127.13 millions was observed in the OP in the quarter ended June 2022 from 273.62 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 721.10 727.52 -0.88 721.10 727.52 -0.88 2727.98 2834.73 -3.77
Other Income 12.45 9.43 32.03 12.45 9.43 32.03 90.80 68.23 33.08
PBIDT 127.13 273.62 -53.54 127.13 273.62 -53.54 817.28 1075.34 -24.00
Interest 0.28 0.08 250.00 0.28 0.08 250.00 0.95 1.00 -5.00
PBDT 126.85 273.54 -53.63 126.85 273.54 -53.63 816.33 1074.34 -24.02
Depreciation 24.09 22.68 6.22 24.09 22.68 6.22 95.61 90.06 6.16
PBT 102.76 250.86 -59.04 102.76 250.86 -59.04 720.72 984.28 -26.78
TAX 24.98 65.38 -61.79 24.98 65.38 -61.79 175.61 274.16 -35.95
Deferred Tax -1.08 0.24 -550.00 -1.08 0.24 -550.00 -4.56 25.72 -117.73
PAT 77.78 185.48 -58.07 77.78 185.48 -58.07 545.11 710.12 -23.24
Equity 223.61 223.56 0.02 223.61 223.56 0.02 223.60 223.46 0.06
PBIDTM(%) 17.63 37.61 -53.12 17.63 37.61 -53.12 29.96 37.93 -21.02

Advanced Enzyme Share Price

299.15 0.30 (0.10%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×